BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Diagnosis
100 results:

  • 1. Downregulation of praja2 restrains endocytosis and boosts tyrosine kinase receptors in kidney cancer.
    Rinaldi L; Chiuso F; Senatore E; Borzacchiello D; Lignitto L; Iannucci R; Donne RD; Fuggi M; Reale C; Russo F; Russo NA; Giurato G; Rizzo F; Sellitto A; Santangelo M; De Biase D; Paciello O; D'Ambrosio C; Amente S; Garbi C; Dalla E; Scaloni A; Weisz A; Ambrosino C; Insabato L; Feliciello A
    Commun Biol; 2024 Feb; 7(1):208. PubMed ID: 38379085
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Oncological and functional outcomes of patients who underwent open partial nephrectomy for kidney tumor.
    Bosnalı E; Baynal EA; Çınar NB; Akdas EM; Telli E; Yaprak Bayrak B; Teke K; Yılmaz H; Dillioğlugil Ö; Kara Ö
    Arch Ital Urol Androl; 2023 Dec; 95(4):12130. PubMed ID: 38193219
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Efficacy and late kidney effects of nephron-sparing surgery in the management of unilateral Wilms tumor: a systematic review and meta-analysis.
    Li S; Wang J; Li M; Zhang Z; Mi T; Wu X; Wang Z; Jin L; He D
    Pediatr Surg Int; 2023 Dec; 40(1):29. PubMed ID: 38150145
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Afatinib-Induced Tumor Lysis Syndrome in Pulmonary Adenocarcinoma: A Case Report and Literature Review.
    Hong G
    Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138247
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Giant left pheochromocytoma with vascular anomalies and pelvic horseshoe kidney: a case report.
    Biben E; Menon L; Gokden N; Spond MF; Eichhorn JM; Aydin AM
    BMC Urol; 2023 Dec; 23(1):204. PubMed ID: 38066479
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Long-term renal function following radical cystectomy and ileal conduit creation.
    Chevarria J; Ebad CA; Hamill M; Constandache C; Cowhig C; Little DM; Conlon PJ
    Ir J Med Sci; 2024 Apr; 193(2):639-644. PubMed ID: 37742311
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Cardiorespiratory fitness and BMI measured in youth and 5-year mortality after site-specific cancer diagnoses in men-A population-based cohort study with register linkage.
    Onerup A; Mehlig K; Ekblom-Bak E; Lissner L; Börjesson M; Åberg M
    Cancer Med; 2023 Oct; 12(19):20000-20014. PubMed ID: 37732468
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. kidney Function and Risk of Renal Cell Carcinoma.
    Alcala K; Zahed H; Cortez Cardoso Penha R; Alcala N; Robbins HA; Smith-Byrne K; Martin RM; Muller DC; Brennan P; Johansson M
    Cancer Epidemiol Biomarkers Prev; 2023 Nov; 32(11):1644-1650. PubMed ID: 37668600
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Immune-related acute kidney injury in Australian non-small cell lung cancer patients: Real-world results.
    Knox A; Cloney T; Janssen H; Solomon BJ; Alexander M; Ruderman I; John T
    Lung Cancer; 2023 Oct; 184():107325. PubMed ID: 37573702
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Partial versus radical nephrectomy for complex renal mass: multicenter comparative analysis of functional outcomes (Rosula collaborative group).
    Cerrato C; Meagher MF; Autorino R; Simone G; Yang B; Uzzo RG; Kutikov A; Porpiglia F; Capitanio U; Montorsi F; Porter J; Beksac AT; Puri D; Nguyen M; Wang L; Hakimi K; Dhanji S; Liu F; Cerruto MA; Pandolfo SD; Minervini A; Lau C; Monish A; Eun D; Mottrie A; Mir C; Sundaram C; Antonelli A; Kaouk J; Derweesh IH
    Minerva Urol Nephrol; 2023 Aug; 75(4):425-433. PubMed ID: 37530659
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A Predictive Model for kidney Failure After Nephrectomy for Localized kidney Cancer: The kidney Cancer Risk Equation.
    Harasemiw O; Nayak JG; Grubic N; Ferguson TW; Sood MM; Tangri N
    Am J Kidney Dis; 2023 Dec; 82(6):656-665. PubMed ID: 37394174
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Endophytic upper tract urothelial carcinoma in a solitary kidney treated by cryotherapy: an unorthodox case for successful management.
    Abdelaziz A; Sultan M; Hammad MA; Martinez JR; Yacoub M; Youssef RF
    BMC Urol; 2023 Jun; 23(1):111. PubMed ID: 37370049
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Clinical and genomic features in patients with second primary glioblastoma following first primary renal cell carcinoma.
    Zhang GT; Liu Q; Zuo FX; Liu HJ; Wang SQ; Yuan Q; Liu AS; Hu K; Meng XL; Wang WJ; Qian HP; Wan JH; Cai HQ
    BMC Cancer; 2023 Jan; 23(1):104. PubMed ID: 36717819
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinical phenotypes and long-term outcome of kidney involvement in Erdheim-Chester histiocytosis.
    Chazal T; Pegoraro F; Manari G; Bettiol A; Maniscalco V; Gelain E; Charlotte F; Mazor RD; Renard-Penna R; Amoura Z; Cohen-Aubart F; Haroche J; Izzedine H; Vaglio A
    Kidney Int; 2023 Jan; 103(1):177-186. PubMed ID: 36374823
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Clinical analysis of three-dimensional surgical planning system for guiding robot-assisted selective artery clamping partial nephrectomy in completely endophytic renal tumor].
    Guo SJ; Wei LC; Zhuo SQ; Wang YJ; Yang XY; Zhang ZL; Dong P; Zhou FJ; Han H
    Zhonghua Wai Ke Za Zhi; 2022 Nov; 60(11):992-998. PubMed ID: 36323581
    [No Abstract]    [Full Text] [Related]  

  • 16. Shrunken pore syndrome in childhood cancer survivors treated with potentially nephrotoxic therapy.
    Kooijmans ECM; van der Pal HJH; Pilon MCF; Pluijm SMF; van der Heiden-van der Loo M; Kremer LCM; Bresters D; van Dulmen-den Broeder E; van den Heuvel-Eibrink MM; Loonen JJ; Louwerens M; Neggers SJC; van Santen HM; Tissing WJE; de Vries ACH; Kaspers GJL; Veening MA; Bökenkamp A;
    Scand J Clin Lab Invest; 2022; 82(7-8):541-548. PubMed ID: 36200802
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Analysis of long-term renal function in patients with malignant solid tumors: Retrospective analysis using the estimated glomerular filtration rate.
    Sano H; Kobayashi R; Matsushima S; Hori D; Yanagi M; Kodama K; Suzuki D; Kobayashi K
    Pediatr Int; 2022 Jan; 64(1):e15373. PubMed ID: 36176204
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Micropeptide MIAC inhibits the tumor progression by interacting with AQP2 and inhibiting EREG/egfr signaling in renal cell carcinoma.
    Li M; Liu G; Jin X; Guo H; Setrerrahmane S; Xu X; Li T; Lin Y; Xu H
    Mol Cancer; 2022 Sep; 21(1):181. PubMed ID: 36117171
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Differential expression profiling of onco and tumor-suppressor genes from major-signaling pathways in Wilms' tumor.
    Sahu DK; Singh N; Das M; Rawat J; Gupta DK
    Pediatr Surg Int; 2022 Nov; 38(11):1601-1617. PubMed ID: 36107237
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Risk of malignancy in patients with chronic kidney disease.
    Tendulkar KK; Cope B; Dong J; Plumb TJ; Campbell WS; Ganti AK
    PLoS One; 2022; 17(8):e0272910. PubMed ID: 35976968
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.